Logo image of ANGN

ANGION BIOMEDICA CORP (ANGN) Stock Analyst Ratings

NASDAQ:ANGN - Nasdaq - US03476J1079 - Common Stock - Currency: USD

1  +0.02 (+2.04%)

After market: 0.9437 -0.06 (-5.63%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to ANGN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.53. This target is 53% above the current price.
ANGN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ANGN.
In the previous month the buy percentage consensus was at a similar level.
ANGN was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

ANGN Historical Analyst RatingsANGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 1.001.521.531.531.58 - 51.50% 53.00% 53.00% 57.50%

Related screens

ANGN Current Analyst RatingANGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2022-07-18 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-06-30 Oppenheimer Downgrade Outperform -> Perform
2022-06-30 Stifel Downgrade Buy -> Hold
2022-05-23 HC Wainwright & Co. Maintains Buy
2022-04-18 HC Wainwright & Co. Maintains Buy
2021-12-10 Oppenheimer Maintains Outperform
2021-11-09 HC Wainwright & Co. Maintains Buy
2021-10-27 Stifel Maintains Buy
2021-03-02 Oppenheimer Initiate Outperform
2021-03-02 Stifel Initiate Buy
2021-03-02 Cowen & Co. Initiate Outperform
2021-03-01 HC Wainwright & Co. Initiate Buy